Related Experiment Videos
Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
A M Jordan1, J Weingarten, W M Murphy
1Department of Pathology, Baptist Memorial Hospital, Memphis, TN 38146.
Cancer
|December 1, 1987
Summary
Histologic grading of urinary bladder tumors is crucial. Low-grade tumors are benign papillomas, while high-grade neoplasms are aggressive and linked to most deaths, regardless of invasion depth.
Area of Science:
- Uropathology
- Oncology
- Cancer Biology
Background:
- Transitional cell neoplasms of the urinary bladder are increasingly recognized as either nonaggressive low-grade lesions or aggressive anaplastic cancers.
- Understanding the pathological features that reveal the biological potential of these neoplasms is critical for accurate diagnosis and prognosis.
Purpose of the Study:
- To evaluate the extent to which pathological features, specifically histologic grade, predict the biological potential and clinical outcome of transitional cell neoplasms of the urinary bladder.
- To assess the reliability of the World Health Organization (WHO) classification system in grading these tumors.
Main Methods:
- A series of 400 transitional cell neoplasms were classified using WHO guidelines.
- Tumors were selected based on long-term patient follow-up to correlate pathological findings with clinical outcomes.
- Classification was based on established guidelines from experimental models.
Main Results:
- Almost all transitional cell tumors can be reliably graded into low and high grades at initial presentation.
- Low-grade lesions (WHO Grade I) behave benignly and are better classified as papillomas, not carcinomas.
- High-grade neoplasms exhibit aggressive behavior, are responsible for over 93% of tumor-related deaths, and reduce life expectancy even without progression.
- Histologic grade is a more powerful predictor of outcome than depth of invasion or growth pattern.
Conclusions:
- Histologic grading of initial transitional cell tumor tissue is highly predictive of patient outcome.
- Distinguishing between low-grade (papilloma) and high-grade (aggressive carcinoma) transitional cell neoplasms is essential for effective patient management and prognosis.
- The WHO classification system provides a robust framework for grading these tumors.